Only 72 hours left to register to hear how Texas Oncology is keeping up with Precision Medicine advances… 
LATEST NEWS
July 8, 2020
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the...
Read More
July 8, 2020
Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision Oncology Solutions
Sema4, a patient-centered health intelligence company, today announced the launch of Sema4 Signal™, a new family of products and services providing data-driven precision oncology...
Read More
July 8, 2020
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied...
Read More
July 7, 2020
University of Glasgow Awarded £38M to Deliver Game-Changing Precision Medicine Project
The University of Glasgow has been awarded £38m to create the Precision Medicine Living Lab – an internationally leading project focused on translating cutting-edge...
Read More
July 1, 2020
PFIZER AND BIONTECH ANNOUNCE EARLY POSITIVE DATA FROM AN ONGOING PHASE 1/2 STUDY OF MRNA-BASED VACCINE CANDIDATE AGAINST SARS-COV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their...
Read More
July 1, 2020
Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development
Genome Medical today announced that it has raised $14 million to expand its clinical genetics care and operations. The funds will specifically support the...
Read More
